Timely synthesis of the adenovirus type 5 E1B 55-kilodalton protein is required for efficient genome replication in normal human cells

Journal of Virology

Volumn 86, Issue 6, 2012, Pages 3064-3072

  Chahal, Jasdave S ^a   Flint, S J ^a  

^a PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; E1B PROTEIN; MRE11 PROTEIN; NIBRIN; RAD50 PROTEIN; VIRUS DNA;

ADENOVIRUS 5; ADENOVIRUS INFECTION; ARTICLE; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; EPITHELIUM CELL; FRAMESHIFT MUTATION; GENE DELETION; GENE EXPRESSION PROFILING; GENE REPLICATION; GENE SEQUENCE; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SKIN FIBROBLAST; VIRUS CELL TRANSFORMATION; VIRUS GENE; VIRUS GENOME; VIRUS REPLICATION;

ADENOVIRUS E1B PROTEINS; ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; CELL LINE; DNA REPLICATION; GENOME, VIRAL; HUMANS; MOLECULAR WEIGHT; PROTEIN BIOSYNTHESIS; VIRUS REPLICATION;

HUMAN ADENOVIRUS TYPE 5;

EID: 84857982953     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06764-11     Document Type: Article

References (108)

1. Ackrill AM, et al. 1991. Inhibition of the cellular response to interferons by products of the adenovirus type 5 E1A oncogene. Nucleic Acids Res. 19:4387- 4393.
2. Appledorn DM, et al. 2008. Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo. J. Immunol. 181:2134 -2144.
3. Araujo FD, Stracker TH, Carson CT, Lee DV, Weitzman MD. 2005. Adenovirus type 5 E4orf3 protein targets the Mre11 complex to cytoplasmic aggresomes. J. Virol. 79:11382-11391.
4. Babiss LE, Ginsberg HS. 1984. Adenovirus type 5 early region 1b gene product is required for efficient shutoff of host protein synthesis. J. Virol. 50:202-212.
5. Babiss LE, Ginsberg HS, Fisher PB. 1983. Cold-sensitive expression of transformation by a host-range mutant of type 5 adenovirus. Proc. Natl. Acad. Sci. U. S. A. 80:1352-1356.
6. Babiss LE, Young CSH, Fisher PP, Ginsberg HS. 1983. Expression of adenovirus E1A and E1B gene products and the Escherichia coli XPRT gene in KB cells. J. Virol. 46:454-465.
7. Baker A, Rohleder KJ, Hanakahi LA, Ketner G. 2007. Adenovirus E4 34k and E1b 55k oncoproteins target hostDNAligase IV for proteasomal degradation. J. Virol. 81:7034 -7040.
8. Barlan AU, Griffin TM, McGuire KA, Wiethoff CM. 2011. Adenovirus membrane penetration activates the NLRP3 inflammasome. J. Virol. 85: 146-155.
9. Basner-Tschakarjan E, et al. 2006. Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-alpha production. J. Gene Med. 8:1300 -1306.
10. Berk AJ. 2007. Adenoviridae: the viruses and their replication, p 2355- 2394. In Knipe DM and Howley PM (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
11. Bischoff JR, et al. 1996. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274:373-376.
12. Blackford AN, Grand RJ. 2009. Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation. J. Virol. 83: 4000-4012.
13. Blair Zajdel ME, Blair GE. 1988. The intracellular distribution of the transformation-associated protein p53 in adenovirus-transformed rodent cells. Oncogene 2:579 -584.
14. Blanchette P, et al. 2008. Control of mRNA export by adenovirus E4orf6 and E1B55K proteins during productive infection requires E4orf6 ubiquitin ligase activity. J. Virol. 82:2642-2651.
15. Boyer JL, Ketner G. 2000. Genetic analysis of a potential zinc-binding domain of the adenovirus E4 34k protein. J. Biol. Chem. 275:14969- 14978.
16. Cardoso FM, Kato SE, Huang W, Flint SJ, Gonzalez RA. 2008. An early function of the adenoviral E1B 55 kDa protein is required for the nuclear relocalization of the cellular p53 protein in adenovirus-infected normal human cells. Virology 378:339 -346.
17. Carvalho T, et al. 1995. Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J. Cell Biol. 131: 45-56.
18. Cerullo V, et al. 2007. Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors. Mol. Ther. 15:378- 385.
19. Cheng CY, Blanchette P, Branton PE. 2007. The adenovirus E4orf6 E3 ubiquitin ligase complex assembles in a novel fashion. Virology 364:36 - 44.
20. Chiou SK, Tseng CC, Rao L, White E. 1994. Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells. J. Virol. 68:6553- 6566.
21. Colonna M. 2007. TLR pathways and IFN-regulatory factors: to each its own. Eur. J. Immunol. 37:306 -309.
22. Dallaire F, Blanchette P, Groitl P, Dobner T, Branton PE. 2009. Identification of integrin alpha3 as a new substrate of the adenovirus E4orf6/E1B 55-kilodalton E3 ubiquitin ligase complex. J. Virol. 83:5329- 5338.
23. D'Amours D, Jackson SP. 2002. The Mre11 complex: at the crossroads ofDNArepair and checkpoint signalling. Nat. Rev. Mol. Cell Biol. 3:317- 327.
24. Debbas M, White E. 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:546 -554.
25. Dosch T, et al. 2001. The adenovirus type 5 E1B-55k oncoprotein actively shuttles in virus-infected cells, whereas transport of E4Orf6 is mediated by a CRM1-independent mechanism. J. Virol. 75:5677-5683.
26. Doucas V, et al. 1996. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev. 10:196 -207.
27. Endter C, Hartl B, Spruss T, Hauber J, Dobner T. 2005. Blockage of CRM1-dependent nuclear export of the adenovirus type 5 early region 1B 55-kDa protein augments oncogenic transformation of primary rat cells. Oncogene 24:55- 64.
28. Endter C, Kzhyshkowska J, Stauber R, Dobner T. 2001. SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein. Proc. Natl. Acad. Sci. U. S. A. 98:11312- 11317.
29. Evans JD, Hearing P. 2003. Distinct roles of the Adenovirus E4 ORF3 protein in viral DNA replication and inhibition of genome concatenation. J. Virol. 77:5295-5304.
30. Evans JD, Hearing P. 2005. Relocalization of the Mre11-Rad50-Nbs1 complex by the adenovirus E4 ORF3 protein is required for viral replication. J. Virol. 79:6207- 6215.
31. Flint SJ, Gonzalez RA. 2003. Regulation of mRNA production by the adenoviral E1B 55kDa and E4 Orf6 proteins. Curr. Top. Microbiol. Immunol. 272:287-330.
32. Gonzalez R, Huang W, Finnen R, Bragg C, Flint SJ. 2006. Adenovirus E1B 55-kilodalton protein is required for both regulation of mRNA export and efficient entry into the late phase of infection in normal human fibroblasts. J. Virol. 80:964 -974.
33. Gonzalez RA, Flint SJ. 2002. Effects of mutations in the adenoviral E1B 55 kDa protein coding sequence on viral latemRNAmetabolism. J. Virol. 76:4507- 4519.
34. Goodrum FD, Ornelles DA. 1997. The early region 1B 55-kilodalton oncoprotein of adenovirus relieves growth restrictions imposed on viral replication by the cell cycle. J. Virol. 71:548 -561.
35. Goodrum FD, Ornelles DA. 1999. Roles for the E4 orf6, orf3, and E1B 55-kilodalton proteins in cell cycle-independent adenovirus replication. J. Virol. 73:7474 -7488.
36. Grand RJ, Grant ML, Gallimore PH. 1994. Enhanced expression of p53 in human cells infected with mutant adenoviruses. Virology 203:229- 240.
37. Gutch MJ, Reich NC. 1991. Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene. Proc. Natl. Acad. Sci. U. S. A. 88:7913-7917.
38. Harada JN, Berk AJ. 1999. p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication. J. Virol. 73:5333- 5344.
39. Harada JN, Shevchenko A, Pallas DC, Berk AJ. 2002. Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery. J. Virol. 76:9194 -9206.
40. He TC, et al. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U. S. A. 95:2509 -2514.
41. Hobom U, Dobbelstein M. 2004. E1B-55-kilodalton protein is not required to block p53-induced transcription during adenovirus infection. J. Virol. 78:7685-7697.
42. Hutton FG, Turnell AS, Gallimore PH, Grand RJ. 2000. Consequences of disruption of the interaction between p53 and the larger adenovirus early region 1B protein in adenovirus E1 transformed human cells. Oncogene 19:452- 462.
43. Kalvakolanu DV, Bandyopadhyay SK, Harter ML, Sen GC. 1991. Inhibition of interferon-inducible gene expression by adenovirus E1A proteins: block in transcriptional complex formation. Proc. Natl. Acad. Sci. U. S. A. 88:7459 -7463.
44. Kato SE, Huang W, Flint SJ. 2011. Role of the RNA recognition motif of the E1B 55kDa protein in the adenovirus type 5 infectious cycle. Virology.
45. Kitajewski J, et al. 1986. Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced eIF-2 alpha kinase. Cell 45:195-200.
46. Kitajewski J, Schneider RJ, Safer B, Shenk T. 1986. An adenovirus mutant unable to express VAI RNA displays different growth responses and sensitivity to interferon in various host cell lines. Mol. Cell. Biol. 6:4493- 4498.
47. Krätzer F, et al. 2000. The adenovirus type 5 E1B-55K oncoprotein is a highly active shuttle protein and shuttling is independent of E4orf6, p53 and Mdm2. Oncogene 19:850-857.
48. Lakdawala SS, et al. 2008. Differential requirements of the C terminus of Nbs1 in suppressing adenovirus DNA replication and promoting concatemer formation. J. Virol. 82:8362- 8372.
49. Lassam NJ, Bayley ST, Graham FL. 1979. Tumor antigens of human Ad5 in transformed cells and in cells infected with transformation defective host range mutants. Cell 18:781-791.
50. Lavin MF. 2007.ATMand the Mre11 complex combine to recognize and signal DNA double-strand breaks. Oncogene 26:7749 -7758.
51. Leppard KN, Everett RD. 1999. The adenovirus type 5 E1b 55K and E4 Orf3 proteins associate in infected cells and affect ND10 components. J. Gen. Virol. 80:997-1008.
52. Liu Y, Shevchenko A, Berk AJ. 2005. Adenovirus exploits the cellular aggresome response to accelerate inactivation of the MRN complex. J. Virol. 79:14004 -14016.
53. Luo K, et al. 2007. Adenovirus E4orf6 assembles with Cullin5-ElonginBElonginC E3 ubiquitin ligase through an HIV/SIV Vif-like BC-box to regulate p53. FASEB J. 21:1742-1750.
54. Martin ME, Berk AJ. 1998. Adenovirus E1B 55K represses p53 activation in vitro. J. Virol. 72:3146 -3154.
55. Martin ME, Berk AJ. 1999. Corepressor required for adenovirus E1B 55,000-molecular-weight protein repression of basal transcription. Mol. Cell. Biol. 19:3403-3414.
56. Mathew SS, Bridge E. 2007. The cellular Mre11 protein interferes with adenovirus E4 mutant DNA replication. Virology 365:346 -355.
57. Mathew SS, Bridge E. 2008. Nbs1-dependent binding of Mre11 to adenovirus E4 mutant viral DNA is important for inhibiting DNA replication. Virology 374:11-22.
58. Miller DL, Rickards B, Mashiba M, Huang W, Flint SJ. 2009. The adenoviral E1B 55-kilodalton protein controls expression of immune response genes but not p53-dependent transcription. J. Virol. 83:3591- 3603.
59. Muller S, Dobner T. 2008. The adenovirus E1B-55K oncoprotein induces SUMO modification of p53. Cell Cycle 7:754 -758.
60. Murti KG, Davis DS, Kitchingman GR. 1990. Localization of adenovirus-encoded DNA replication proteins in the nucleus by immunogold electron microscopy. J. Gen. Virol. 71:2847-2857.
61. Nevels M, Rubenwolf S, Spruss T, Wolf H, Dobner T. 2000. Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orf6 protein. J. Virol. 74:5168 -5181.
62. Nevels M, et al. 1999. Transforming potential of the adenovirus type 5 E4orf3 protein. J. Virol. 73:1591-1600.
63. O'Shea CC, et al. 2004. Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity. Cancer Cell 6:611- 623.
64. Pennella MA, Liu Y, Woo JL, Kim CA, Berk AJ. 2010. Adenovirus E1B 55-kilodalton protein is a p53-SUMO1 E3 ligase that represses p53 and stimulates its nuclear export through interactions with promyelocytic leukemia nuclear bodies. J. Virol. 84:12210 -12225.
65. Pilder S, Logan J, Shenk TE. 1984. Deletion of the gene encoding the adenovirus 5 early region 1b 21,000-molecular weight polypeptide leads to degradation of viral and host cell DNA. J. Virol. 52:664-671.
66. Pilder S, Moore M, Logan J, Shenk T. 1986. The adenovirus E1B-55kd transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol. Cell. Biol. 6:470-476.
67. Puvion-Dutilleul F, Pedron J, Cajean-Feroldi C. 1984. Identification of intranuclear structures containing the 72K DNA-binding protein of human adenovirus type 5. Eur. J. Cell Biol. 34:313-322.
68. Querido E, et al. 2001. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullincontaining complex. Genes Dev. 15:3104 -3117.
69. Querido E, et al. 1997. Regulation of p53 levels by the E1B 55-kilodalton protein and E4orf6 in adenovirus-infected cells. J. Virol. 71:3788 -3798.
70. Reich NC, Sarnow P, Duprey E, Levine AJ. 1983. Monoclonal antibodies which recognize native and denatured forms of the adenovirus DNAbinding protein. Virology 128:480-484.
71. Reichel R, Kovesdi I, Nevins JR. 1988. Activation of a pre-existing cellular factor as a basis for adenovirus E1A-mediated transcription control. Proc. Natl. Acad. Sci. U. S. A. 85:387-390.
72. Riches LC, Lynch AM, Gooderham NJ. 2008. Early events in the mammalian response to DNA double-strand breaks. Mutagenesis 23:331- 339.
73. Ross SR, Levine AJ, Galos RS, Williams J, Shenk T. 1980. Early viral proteins in HeLa cells infected with adenovirus type 5 host range mutants. Virology 103:475- 492.
74. Roth J, et al. 1998. Inactivation of p53 but not p73 by adenovirus type 5 E1B 55-kilodalton and E4 34-kilodalton oncoproteins. J. Virol. 72:8510- 8516.
75. Rothmann T, Hengstermann A, Whitaker NJ, Scheffner M, Hzur Hausen. 1998. Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. J. Virol. 72:9470 -9478.
76. Sarnow P, Ho YS, Williams J, Levine AJ. 1982. Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 28:387- 394.
77. Shen Y, Kitzes G, Nye JA, Fattaey A, Hermiston T. 2001. Analyses of single-amino-acid substitution mutants of adenovirus type 5 E1B-55K protein. J. Virol. 75:4297- 4307.
78. Shepard RN, Ornelles DA. 2004. Diverse roles for E4orf3 at late times of infection revealed in an E1B 55-kilodalton protein mutant background. J. Virol. 78:9924 -9935.
79. Soria C, Estermann FE, Espantman KC, O'Shea CC. 2010. Heterochromatin silencing of p53 target genes by a small viral protein. Nature 466:1076 -1081.
80. Spindler KR, Eng CY, Berk AJ. 1985. An adenovirus early region 1A protein is required for maximal viralDNAreplication in growth-arrested human cells. J. Virol. 53:742-750.
81. Steegenga WT, Riteco N, Jochemsen AG, Fallaux FJ, Bos JL. 1998. The large E1B protein together with the E4orf6 protein target p53 for active degradation in adenovirus infected cells. Oncogene 16:349 -357.
82. Stracker TH, Carson CT, Weitzman MD. 2002. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418:348 -352.
83. Stracker TH, et al. 2005. Serotype-specific reorganization of the Mre11 complex by adenoviral E4orf3 proteins. J. Virol. 79:6664-6673.
84. Stracker TH, Petrini JH. 2011. The MRE11 complex: starting from the ends. Nat. Rev. Mol. Cell Biol. 12:90 -103.
85. Subramanian T, Boyd JM, Chinnadurai G. 1995. Functional substitution identifies a cell survival promoting domain common to adenovirus E1B 19 kDa and Bcl-2 proteins. Oncogene 11:2403-2409.
86. Subramanian T, Kuppuswamy M, Mak S, Chinnadurai G. 1984. Adenovirus cyt+ locus, which controls cell transformation and tumorigenicity, is an allele of lp+ locus, which codes for a 19-kilodalton tumor antigen. J. Virol. 52:336 -343.
87. Sugawara K, Gilead Z, Wold WSM, Green M. 1977. Immunofluorescence study of the adenovirus type 2 single-stranded DNA binding protein in infected and transformed cells. J. Virol. 22:527-539.
88. Tarodi B, Subramanian T, Chinnadurai G. 1993. Functional similarity between adenovirus e1b 19k gene and bcl2 oncogene-mutant complementation and suppression of cell-death induced by DNA-damaging agents. Int. J. Oncol. 3:467- 472.
89. Teodoro JG, Branton PE. 1997. Regulation of p53-dependent apoptosis, transcriptional repression, and cell transformation by phosphorylation of the 55-kilodalton E1B protein of human adenovirus type 5. J. Virol. 71:3620 -3627.
90. Teodoro JG, et al. 1994. Phosphorylation at the carboxy terminus of the 55-kilodalton adenovirus type 5 E1B protein regulates transforming activity. J. Virol. 68:776 -786.
91. Turnell AS, Grand RJ, Gallimore PH. 1999. The replicative capacities of large E1B-null group A and group C adenoviruses are independent of host cell p53 status. J. Virol. 73:2074 -2083.
92. Uematsu S, Akira S. 2007. Toll-like receptors and Type I interferons. J. Biol. Chem. 282:15319 -15323.
93. Ullman AJ, Hearing P. 2008. Cellular proteins PML and Daxx mediate an innate antiviral defense antagonized by the adenovirus E4 ORF3 protein. J. Virol. 82:7325-7335.
94. Ullman AJ, Reich NC, Hearing P. 2007. Adenovirus E4 ORF3 protein inhibits the interferon-mediated antiviral response. J. Virol. 81:4744- 4752.
95. van den Bosch M, Bree RT, Lowndes NF. 2003. The MRN complex: coordinating and mediating the response to broken chromosomes. EMBO Rep. 4:844-849.
96. Voelkerding K, Klessig DF. 1986. Identification of two nuclear subclasses of the adenovirus type 5-encoded DNA-binding protein. J. Virol. 60:353-362.
97. Watters TM, Kenny EF, O'Neill LA. 2007. Structure, function and regulation of the Toll/IL-1 receptor adaptor proteins. Immunol. Cell Biol. 85:411- 419.
98. Weiden MD, Ginsberg HS. 1994. Deletion of the E4 region of the genome produces adenovirus DNA concatemers. Proc. Natl. Acad. Sci. U. S. A. 91:153-157.
99. White E, Grodzicker T, Stillman BW. 1984. Mutations in the gene encoding the adenovirus early region 1B 19,000-molecular-weight tumor antigen cause the degradation of chromosomal DNA. J. Virol. 82: 410-419.
100. Williams J, et al. 1986. The adenovirus E1B 495R protein plays a role in regulating the transport and stability of the viral late messages. Cancer Cells 4:275-284.
101. Williams JF. 1970. Enhancement of adenovirus plaque formation on HeLa cells by magnesium chloride. J. Gen. Virol. 9:251-253.
102. Wold WSM, Horwitz MS. 2007. Adenoviruses, p 2395-2436. In Knipe DM and Howley PM (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
103. Woo JL, Berk AJ. 2007. Adenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export. J. Virol. 81:575-587.
104. Yamaguchi T, et al. 2007. Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors. Hum. Gene Ther. 18:753-762.
105. Yew PR, Berk AJ. 1992. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature 357:82- 85.
106. Yew PR, Liu X, Berk AJ. 1994. Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53. Genes Dev. 8:190 -202.
107. Zantema A, et al. 1985. Localization of the E1B proteins of adenovirus 5 in transformed cells, as revealed by interaction with monoclonal antibodies. Virology 142:44 -58.
108. Zhu J, Huang X, Yang Y. 2007. Innate immune response to adenoviral vectors is mediated by both Toll-like receptor-dependent and -independent pathways. J. Virol. 81:3170 -3180.